<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00767013</url>
  </required_header>
  <id_info>
    <org_study_id>Cardiac imaging DSCT</org_study_id>
    <nct_id>NCT00767013</nct_id>
  </id_info>
  <brief_title>Preoperative Assessment of Aortic Valve Stenosis and Coronary Artery Disease</brief_title>
  <official_title>Preoperative Assessment of Aortic Valve Stenosis and Coronary Artery Disease: Dual-source Computed Tomography Compared With Invasive Coronary Angiography and Transthoracic Echocardiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We sought to determine whether the dual-source computed tomography assessment of aortic valve
      stenosis and coronary artery disease is equivalent to or even better than conventional
      invasive coronary angiography and transthoracic echocardiography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Until now invasive coronary angiography has established itself for the assessment of
      symptomatic aortic valve stenosis. Literature shows a good correlation between MSCT, MRI, TTE
      and TEE for evaluating the severity of the aortic valve stenosis.

      The dual-source computed tomography (DSCT) is capable of assessing coronary arteries with a
      high sensitivity and specificity in term of relevant stenosis (&gt;50%), due to its excellent
      spatial and temporal resolution. This study includes the assessment of patients with
      symptomatic valve stenosis. The severity of the aortic valve stenosis is being assessed by
      DSCT and TTE. Significant coronary artery stenosis and its localisation are assessed by DSCT
      and invasive coronary angiography. We examine the correlation between DSCT on one side and
      either TTE or invasive coronary angiography on the other.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of cardiac imaging in computed tomography</measure>
    <time_frame>After comparison of imaging measurements</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>AVS, CAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DSCT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>DSCT, TTE</intervention_name>
    <description>One assessment each</description>
    <arm_group_label>AVS, CAD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with aortic valve disease who were scheduled to undergo cardiac surgery

        Exclusion Criteria:

          -  Hemodynamic instability

          -  Renal insufficiency (serum creatinine level &gt; 133umol/L)

          -  Known allergy to iodinated contrast agents

          -  Non-treated hyperthyreosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Erne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Luzerner Kantonsspital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Luzerner Kantonsspital, Department of Cardiology</name>
      <address>
        <city>Lucerne</city>
        <state>Luzern</state>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Erne, MD</last_name>
      <phone>++41 41 205 51 06</phone>
      <email>paul.erne@ksl.ch</email>
    </contact>
    <contact_backup>
      <last_name>Christoph Auf der Maur, MD</last_name>
      <phone>++41 41 2005 51 48</phone>
    </contact_backup>
    <investigator>
      <last_name>Paul Erne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christoph Auf der Maur, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2008</study_first_submitted>
  <study_first_submitted_qc>October 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2008</study_first_posted>
  <last_update_submitted>April 16, 2013</last_update_submitted>
  <last_update_submitted_qc>April 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Luzerner Kantonsspital</investigator_affiliation>
    <investigator_full_name>Prof. Paul Erne</investigator_full_name>
    <investigator_title>Prof. Paul Erne</investigator_title>
  </responsible_party>
  <keyword>DSCT, coronary artery disease, aortic valve stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

